ATE483455T1 - Mischkristalle sowie sie enthaltende pharmazeutische zusammensetzungen - Google Patents
Mischkristalle sowie sie enthaltende pharmazeutische zusammensetzungenInfo
- Publication number
- ATE483455T1 ATE483455T1 AT05754106T AT05754106T ATE483455T1 AT E483455 T1 ATE483455 T1 AT E483455T1 AT 05754106 T AT05754106 T AT 05754106T AT 05754106 T AT05754106 T AT 05754106T AT E483455 T1 ATE483455 T1 AT E483455T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- mixed crystals
- mixed
- crystal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/10—Succinic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/15—Fumaric acid
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57524704P | 2004-05-28 | 2004-05-28 | |
| PCT/US2005/018636 WO2005117585A1 (en) | 2004-05-28 | 2005-05-27 | Mixed co-crystals and pharmaceutical compositions comprising the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE483455T1 true ATE483455T1 (de) | 2010-10-15 |
Family
ID=35462668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05754106T ATE483455T1 (de) | 2004-05-28 | 2005-05-27 | Mischkristalle sowie sie enthaltende pharmazeutische zusammensetzungen |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7671093B2 (de) |
| EP (1) | EP1755388B1 (de) |
| JP (1) | JP2008501024A (de) |
| AT (1) | ATE483455T1 (de) |
| DE (1) | DE602005023986D1 (de) |
| WO (1) | WO2005117585A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2633180A1 (en) * | 2005-12-13 | 2007-06-21 | Harkness Pharmaceuticals, Inc. | Methods of treating obesity using enterostatin |
| WO2007070563A2 (en) * | 2005-12-13 | 2007-06-21 | Harkness Pharmaceuticals, Inc. | Stable solid forms of enterostatin |
| AU2007272954A1 (en) * | 2006-07-11 | 2008-01-17 | Harkness Pharmaceuticals, Inc. | Methods of treating obesity using satiety factors |
| WO2008045473A1 (en) * | 2006-10-11 | 2008-04-17 | Transform Pharmaceuticals, Inc. | Novel crystal of n-[[(5s)-3-[4-(2,6-dihydro-2-methylpyrolo[3,4-c] pyrazol-5(4h)-yl)-3-fluoropheny]-2-oxo-5-oxazolidinyl]methyl] acetamide |
| GB0702402D0 (en) | 2007-02-08 | 2007-03-21 | Thar Pharmaceuticals Inc | Method of creating crystalline substances |
| WO2008138755A2 (en) * | 2007-05-11 | 2008-11-20 | F. Hoffmann-La Roche Ag | Pharmaceutical compositions for poorly soluble drugs |
| DE102007030695A1 (de) * | 2007-07-01 | 2009-01-08 | Sciconcept Gmbh | Co-Kristalle aus Harnstoff mit Amid- und/oder Harnstoffderivaten |
| JP5453693B2 (ja) * | 2007-10-29 | 2014-03-26 | ディーエスエム アイピー アセッツ ビー．ブイ． | レスベラトロルおよびペクチンを含有する組成物 |
| GB0813709D0 (en) * | 2008-07-26 | 2008-09-03 | Univ Dundee | Method and product |
| US8318807B2 (en) | 2010-02-03 | 2012-11-27 | Laurus Labs Private Limited | Pterostilbene cocrystals |
| GB201411802D0 (en) | 2014-07-02 | 2014-08-13 | Univ Bradford | Effervescent compositions |
| CN110354081A (zh) * | 2019-08-01 | 2019-10-22 | 聊城高新生物技术有限公司 | 可减少在水介质中析出的利托那韦固体分散体的制备方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| US5366738A (en) | 1982-07-29 | 1994-11-22 | Merck & Co., Inc. | Controlled release drug dispersion delivery device |
| IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
| IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
| US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
| US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
| US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
| IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
| US6365185B1 (en) | 1998-03-26 | 2002-04-02 | University Of Cincinnati | Self-destructing, controlled release peroral drug delivery system |
| US20030236236A1 (en) | 1999-06-30 | 2003-12-25 | Feng-Jing Chen | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
| US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| WO2004078161A1 (en) * | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazeptine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| WO2004026235A2 (en) * | 2002-09-20 | 2004-04-01 | Transform Pharmaceuticals, Inc. | Pharmaceutical compositions with improved dissolution |
| US6992219B2 (en) * | 2002-08-09 | 2006-01-31 | Cephalon France | Modafinil polymorphic forms |
| MXPA06002507A (es) | 2003-09-04 | 2006-06-20 | Cephalon Inc | Composiciones de modafinil. |
| US8153159B2 (en) * | 2003-09-18 | 2012-04-10 | Cephalon, Inc. | Modafinil modified release pharmaceutical compositions |
-
2005
- 2005-05-27 DE DE602005023986T patent/DE602005023986D1/de active Active
- 2005-05-27 AT AT05754106T patent/ATE483455T1/de not_active IP Right Cessation
- 2005-05-27 EP EP05754106A patent/EP1755388B1/de active Active
- 2005-05-27 US US11/139,245 patent/US7671093B2/en not_active Expired - Fee Related
- 2005-05-27 JP JP2007515366A patent/JP2008501024A/ja active Pending
- 2005-05-27 WO PCT/US2005/018636 patent/WO2005117585A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| US20050267209A1 (en) | 2005-12-01 |
| WO2005117585A1 (en) | 2005-12-15 |
| EP1755388B1 (de) | 2010-10-06 |
| JP2008501024A (ja) | 2008-01-17 |
| EP1755388A4 (de) | 2009-09-16 |
| EP1755388A1 (de) | 2007-02-28 |
| US7671093B2 (en) | 2010-03-02 |
| DE602005023986D1 (de) | 2010-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE483455T1 (de) | Mischkristalle sowie sie enthaltende pharmazeutische zusammensetzungen | |
| NO20065726L (no) | Forbindelser og sammensetninger for avlevering av aktive forbindelser. | |
| EA200700118A1 (ru) | Амидосоединения и их применение в качестве лекарственных средств | |
| SV2006002174A (es) | Composicion de anticuerpo her2 | |
| NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
| SE0301700D0 (sv) | Novel compounds | |
| DK1934174T3 (da) | Azetidiner som MEK inhibitorer til behandling af proliferative sygdomme | |
| EA200701065A1 (ru) | Инъецируемые составы, содержащие нанодисперсный оланзапин | |
| UY30748A1 (es) | Compuesto0s novedosos | |
| BRPI0417684A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0515594A (pt) | inibidores da interação entre mdm2 e p53 | |
| CY1111197T1 (el) | Tριαζολες χρησιμες ως αναστολεις πρετεϊνικων κινασων | |
| BR0113286B1 (pt) | pirazàis substituÍdos e composiÇço farmacÊutica compreendendo os mesmos. | |
| BRPI0508579A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| EA201000436A1 (ru) | Стероидные [3,2-с]пиразольные соединения, обладающие глюкокортикоидной активностью | |
| ATE486587T1 (de) | Formulierungen zur oralen verabreichung von wirkstoffen | |
| EA200601279A1 (ru) | Пиперидинилкарбонилпирролидины и их применение в качестве агонистов меланокортина | |
| NO20062739L (no) | Kontrollert frigivining av topirimat i flytende doseringsform | |
| AR109263A2 (es) | Composición que comprende moxidectina | |
| SE0401762D0 (sv) | Novel compounds | |
| BRPI0512986A (pt) | novos derivados de hidantoìna | |
| ATE462703T1 (de) | Bicyclononen-derivate als renin-inhibitoren | |
| ATE375810T1 (de) | Cyanoamid-verbindungen als nützliche malonyl-coa decarboxylase-hemmer | |
| CY1111574T1 (el) | Παραγωγα βουτανοϊκου οξεος, διαδικασιες για την παρασκευη τους, φαρμακευτικες συνθεσεις που τα περιλαμβανουν και θεραπευτικες εφαρμογες αυτων | |
| NO20065231L (no) | Nye imidazoler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |